Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 12-month price […]
BI Asset Management Fondsmaeglerselskab A S decreased its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 6.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 69,234 shares of the company’s stock after selling 4,743 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Elevance Health were […]
BI Asset Management Fondsmaeglerselskab A S trimmed its holdings in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 6.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 69,234 shares of the company’s stock after selling 4,743 shares during […]
Newport Trust Company LLC cut its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 2.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,210,519 shares of the company’s stock after selling 31,119 shares during the period. Elevance Health […]
Newport Trust Company LLC cut its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 2.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,210,519 shares of the company’s stock after selling 31,119 shares during the quarter. Elevance Health makes […]